Great news for those taking Namenda!
“The generic for Namenda is now available in pharmacies. A happy day for the caregivers of persons afflicted with Alzheimer’s and dementia worldwide. 21 more words
From the New York Times (New Drug Sharply Lowers Cholesterol, But it’s Costly)
Praluent, which analysts project will become a huge seller, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical prices, and health plans are expected to put in place strict measures to control which patients can use the drug and prevent it from becoming a budget buster. 526 more words
Israel’s Teva Pharmaceuticals Industries Ltd said Monday it’s dropping its hostile bid for Mylan Inc. and hooking up instead with Allergan Inc. .
Tel Aviv-based Teva will buy Allergan’s generics business for $40.5 billion in cash and stock, in a deal that will catapult it into the world’s top 10 pharma companies. 300 more words
Lee Pharma, a Hyderabad based Indian pharma company, has filed a Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the patented drug Saxagliptin for treating Diabetes Mellitus. 913 more words
India revoked yet another drug patent granted to a German MNC, Boehringer Ingelheim, for its respiratory drug, Spiriva (crystalline tiotropium bromide monohydrate) at a time when the US is putting pressure on Indian government for not providing adequate patent protection to multinational drug companies. 726 more words